SEEQC Partners with ITRI to Build Advanced Superconducting Electronic Chip Manufacturing Line
Manufacturing Facilities Will Power Resilient and Robust
Under the partnership, SEEQC will deploy the new manufacturing line to enable a robust and high-yield production environment. The initial phase of the project will focus on technology transfer and process development, with SEEQC's R&D team providing technical expertise throughout the build. The manufactured chips will be delivered to SEEQC's headquarters in
These superconducting digital control chips operate at cryogenic temperatures alongside qubits, handling timing, readout, multiplexing and error-correction logic with ultra-low power, high speed and low latency— essential capabilities to building scalable, fault-tolerant quantum computers.
"Building this capability with a trusted partner creates a diversified manufacturing base for
"ITRI is committed to supporting the advancement of SEEQC's superconducting chip manufacturing technologies," says
Combined with SEEQC's in-house R&D and chip manufacturing facilities in
The announcement underscores SEEQC and ITRI's shared commitment to advancing global innovation in advanced chip manufacturing and building a resilient, distributed supply chain for emerging quantum and superconducting technologies.
About SEEQC
SEEQC designs and manufactures superconducting digital chips, firmware, and software for scalable, energy-efficient quantum computing systems based on its proprietary Single Flux Quantum (SFQ) chips produced at the company's multi-layer superconductive electronics chip foundry located in
Media Contact
Paradox Public Relations
[email protected]
View original content:https://www.prnewswire.com/news-releases/seeqc-partners-with-itri-to-build-advanced-superconducting-electronic-chip-manufacturing-line-302629459.html
SOURCE SEEQC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Real Estate Expert Pamela Z. Hill Explains Why Whidbey Island Is a Popular Destination for Vacation Homes in HelloNation
- HumanEdge, Inc. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Social Security Numbers
- Pulmovant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share